The JAK2/V617F mutation has been noted in essential thrombocytemia. We investigated 19 cases with refractory anemia with ringed sideroblasts (RARS), including three RARS with thrombocytosis (RARS-T). Only the RARS-T patients showed this mutation. More cases need to be analyzed to determine the prevalence of the JAK2/V617F mutation in RARS-T.

Download full-text PDF

Source

Publication Analysis

Top Keywords

anemia ringed
8
ringed sideroblasts
8
jak2/v617f mutation
8
occurrence jak2
4
jak2 v617f
4
mutation
4
v617f mutation
4
mutation provisional
4
provisional entity
4
entity myelodysplastic/myeloproliferative
4

Similar Publications

The ATP-binding cassette (ABC) transporters are a vast group of 48 membrane proteins, some of which are of notable physiological and clinical importance. Some ABC transporters are involved in functions such as the transport of chloride ions, bilirubin, reproductive hormones, cholesterol, and iron. Consequently, genetic or physiological disruption in these functions is manifested in various disease processes like cystic fibrosis, Tangier disease, and sideroblastic anemia.

View Article and Find Full Text PDF

Sideroblastic anemia is characterized by anemia, granulocytopenia, and bone marrow findings of vacuolated precursors and ringed sideroblasts. Zinc-induced copper deficiency can present as sideroblastic anemia and neutropenia. We report the case of a previously healthy 74-year-old female who presented with newly discovered sideroblastic anemia as a result of an over-the-counter oral vitamin and mineral supplement.

View Article and Find Full Text PDF
Article Synopsis
  • A nationwide study involving 2402 patients investigated the prevalence of glycosylphosphatidylinositol-anchored protein-deficient (GPI[-]) cells, specifically PNH-type cells, in individuals with acquired aplastic anaemia (AA) and myelodysplastic syndrome (MDS) using high-sensitivity flow cytometry.
  • PNH-type cells were found in 52.6% of AA patients and 13.7% of MDS patients, while none were present in patients with refractory anaemia having ringed sideroblasts or excess blasts.
  • The study concluded that PNH-type granulocyte levels can change over time in patients with AA and highlighted that having ≥1% PNH-type granul
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!